| Predicate |
Object |
| contentType |
Journal Article |
| endingPage |
1890 |
| issn |
1079-2082
1535-2900 |
| issueIdentifier |
21 |
| pageRange |
1890-1890 |
| publicationName |
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists |
| startingPage |
1890 |
| bibliographicCitation |
Thompson CA. FDA approves pralatrexate for treatment of rare lymphoma. Am J Health Syst Pharm. 2009 Nov 01;66(21):1890. doi: 10.2146/news090080. PMID: 19850775. |
| creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2dbb4208dd6587dc198c14194e5269b7 |
| date |
2009-11-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| identifier |
https://pubmed.ncbi.nlm.nih.gov/19850775
https://doi.org/10.2146/news090080 |
| isPartOf |
https://portal.issn.org/resource/ISSN/1535-2900
https://portal.issn.org/resource/ISSN/1079-2082
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/8629 |
| language |
English |
| source |
https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/ |
| title |
FDA approves pralatrexate for treatment of rare lymphoma |
| discusses |
http://id.nlm.nih.gov/mesh/M0008662
http://id.nlm.nih.gov/mesh/M0000962
http://id.nlm.nih.gov/mesh/M0001483
http://id.nlm.nih.gov/mesh/M0377231 |
| hasPrimarySubjectTerm |
http://id.nlm.nih.gov/mesh/D000630Q000031
http://id.nlm.nih.gov/mesh/D000970Q000627
http://id.nlm.nih.gov/mesh/D016411Q000188 |
| hasSubjectTerm |
http://id.nlm.nih.gov/mesh/D000630Q000627
http://id.nlm.nih.gov/mesh/D014481
http://id.nlm.nih.gov/mesh/D005493Q000627
http://id.nlm.nih.gov/mesh/D017277
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D014486 |
| discussesAsDerivedByTextMining |
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8388
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID148121 |